UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lessened by Bar Harbor Wealth Management

Bar Harbor Wealth Management reduced its stake in UnitedHealth Group (NYSE:UNH) by 8.4% in Q1, now holding 10,776 shares valued at $5.64 million. Other investors, including Capital & Planning LLC and Brighton Jones LLC, increased their holdings. Analysts have downgraded the stock's ratings, with a consensus target price of $426.52. Insiders have also been active, with significant purchases made by directors. The stock is currently trading at $318.14, with a 1-year range of $248.88 to $630.73.

Bar Harbor Wealth Management decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,776 shares of the healthcare conglomerate's stock after selling 992 shares during the quarter. Bar Harbor Wealth Management's holdings in UnitedHealth Group were worth $5,644,000 at the end of the most recent quarter.

Get UnitedHealth Group alerts:

UnitedHealth Stock Dips: Is This a Value Buy Opportunity?

Other institutional investors and hedge funds have also modified their holdings of the company. Capital & Planning LLC raised its position in UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after acquiring an additional 79 shares in the last quarter. Brighton Jones LLC raised its holdings in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA bought a new stake in UnitedHealth Group in the fourth quarter worth $27,233,000. Revolve Wealth Partners LLC raised its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. Finally, Van ECK Associates Corp boosted its stake in shares of UnitedHealth Group by 12.6% during the 4th quarter. Van ECK Associates Corp now owns 196,907 shares of the healthcare conglomerate's stock worth $99,607,000 after acquiring an additional 22,059 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Robert W. Baird cut shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target for the company. in a report on Wednesday. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Finally, TD Securities reaffirmed a "hold" rating and issued a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $426.52.

3 Oversold Stocks Flashing Bullish Reversal Signals

View Our Latest Stock Report on UnitedHealth Group

Insiders Place Their Bets

In related news, Director Kristen Gil bought 3,700 shares of the company's stock in a transaction on Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now owns 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Up 2.4%

3 Trades Members of Congress Are Making Right Now

NYSE UNH opened at $318.14 on Friday. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock's 50 day moving average is $391.47 and its two-hundred day moving average is $476.22. The company has a market capitalization of $288.60 billion, a price-to-earnings ratio of 20.53, a PEG ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the company earned $6.91 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.78%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here